|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Jan 1, 2023
|
FY2021
12 months to Jan 2, 2022
|
|
|---|---|---|---|---|---|
| Sales to customers | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Selling, marketing and administrative expenses | |||||
| Research and development expense | |||||
| In-process research and development impairments | |||||
| Interest income | |||||
| Interest expense, net of portion capitalized | |||||
| Other (income) expense, net | |||||
| Restructuring | |||||
| Earnings before provision for taxes on income | |||||
| Effective Rate | |||||
| Net earnings from continuing operations | |||||
| Net earnings from discontinued operations | |||||
| Net earnings | |||||
| Net earnings per share | |||||
| Basic net earnings per share from continuing operations (in dollars per share) | |||||
| Basic net earnings per share from discontinued operations (in dollars per share) | |||||
| Basic (in dollars per share) | |||||
| Diluted net earnings per share from continuing operations (in dollars per share) | |||||
| Diluted net earnings per share from discontinuing operations (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Average shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
